---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-240513"
form_type: "8-K"
ticker: "VCNX"
cik: "0001205922"
company_name: "VACCINEX, INC."
filed_at: "2023-09-22T23:59:59+00:00"
generated_at: "2026-06-10T09:33:26.304886+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Vaccinex raises ~$582,500 via private placement of 3.7M shares at $0.156/sh

## Summary
- Sold 3,733,973 common shares at $0.156/sh to accredited investors for gross proceeds of ~$582,500.
- CEO-controlled entity Vaccinex (Rochester), L.L.C. participated in the placement.
- Company granted registration rights for resale of shares within 180 days of closing.
- Proceeds to fund pepinemab development and general corporate purposes.

## SEC filing metadata
- accession: 0001193125-23-240513
- form_type: 8-K
- ticker: VCNX
- cik: 0001205922
- company_name: VACCINEX, INC.
- filed_at: 2023-09-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1205922/000119312523240513/0001193125-23-240513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1205922/000119312523240513/d684317d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-240513
- JSON: https://secwatch.observer/filing/0001193125-23-240513.json
- Plain text: https://secwatch.observer/filing/0001193125-23-240513.txt

## Key facts
- Material Agreements
  VACCINEX, INC. entered into Stock Purchase Agreement with the investors named therein (the "Investors") valued at aggregate gross proceeds of approximately $582,500 (effective 2023-09-20).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: the investors named therein (the "Investors")
  - Value: aggregate gross proceeds of approximately $582,500
  - Effective: 2023-09-20
  source text: On September 20, 2023, Vaccinex, Inc. (the “Company”) entered into a stock purchase agreement (the “Stock Purchase Agreement”) pursuant to which the Company agreed to issue and sell to the investors named therein (the “Investors”) an aggregate of 3,733,973 shares of common stock, par value $0.0001 per share, of the Company (the “Shares”), at a purchase price of $0.156 per Share (the “Private Placement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1205922/000119312523240513/0001193125-23-240513-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.